Shares of Allos Therapeutics, Inc. (Nasdaq: ALTH) opened 8% higher this morning after announcing that the FDA granted accelerated approval ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE